切换至 "中华医学电子期刊资源库"

中华损伤与修复杂志(电子版) ›› 2019, Vol. 14 ›› Issue (02) : 145 -148. doi: 10.3877/cma.j.issn.1673-9450.2019.02.013

所属专题: 文献

综述

富血小板血浆在风湿性疾病中的研究进展
段姣妞1, 高晋芳2, 张莉芸2,()   
  1. 1. 030001 太原,山西医科大学附属大医院风湿免疫科
    2. 030032 太原,山西医学科学院 山西大医院风湿免疫科
  • 收稿日期:2019-02-14 出版日期:2019-04-01
  • 通信作者: 张莉芸
  • 基金资助:
    国家自然科学基金(81771768,81202356)

Research progress of platelet-rich plasma in rheumatic diseases

Jiaoniu Duan1, Jinfang Gao2, Liyun Zhang2,()   

  1. 1. Department of Rheumatology and Immunology, Shanxi Dayi Hospital Affiliated to Shanxi Medical University, Taiyuan 030001, China
    2. Department of Rheumatology and Immunology, Shanxi Dayi Hospital of Shanxi Academy of Medical Sciences, Taiyuan 030032, China
  • Received:2019-02-14 Published:2019-04-01
  • Corresponding author: Liyun Zhang
  • About author:
    Corresponding author: Zhang Liyun, Email:
引用本文:

段姣妞, 高晋芳, 张莉芸. 富血小板血浆在风湿性疾病中的研究进展[J/OL]. 中华损伤与修复杂志(电子版), 2019, 14(02): 145-148.

Jiaoniu Duan, Jinfang Gao, Liyun Zhang. Research progress of platelet-rich plasma in rheumatic diseases[J/OL]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2019, 14(02): 145-148.

富血小板血浆(PRP)富含大量生长因子,趋化因子,细胞因子及血浆蛋白,不仅可控制炎症,更有促进组织修复的作用。PRP逐渐成为风湿性疾病治疗的新热点。本文综述了PRP在骨关节炎、类风湿关节炎、干燥综合征、系统性硬化症、结缔组织病相关顽固性皮肤溃疡等疾病中的研究进展。未来需要更多学者积极尝试PRP在其他风湿性疾病中的疗效,同时,PRP联合间充质干细胞治疗在难治性风湿病中具有巨大应用前景。

Platelet-rich plasma(PRP) is enriched by a range of grow factors, chemokines, cytokines, and other plasma proteins, which can suppress inflammation and promote tissue regeneration. The interest in the application of PRP in rheumatology has recently increased. This paper reviews the research progress of PRP in osteoarthritis, rheumatoid arthritis, sjogren′s syndrome, systemic sclerosis, connective tissue disease-associated intractable skin ulcers and so on. In the future, more scholars need to actively try the efficacy of PRP in other rheumatic diseases. At the same time, PRP combined with mesenchymal stem cells has a great application prospect in refractory rheumatic diseases.

[1]
Andia I, Maffulli N. Platelet-rich plasma for managing pain and inflammation in osteoarthritis[J]. Nat Rev Rheumatol, 2013, 9 (12): 721-730.
[2]
Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma(P-PRP)to leucocyte- and platelet-rich fibrin (L-PRF)[J]. Trends Biotechnol, 2009, 27(3): 158-167.
[3]
Alves R, Grimalt R. A Review of Platelet-Rich Plasma: History, Biology, Mechanism of Action, and Classification[J]. Skin Appendage Disord, 2018, 4(1): 18-24.
[4]
Sherwood J. Osteoarthritis year in review 2018: biology[J]. Osteoarthritis Cartilage, 2019, 27(3): 365-370.
[5]
van Buul GM, Koevoet WL, Kops N, et al. Platelet-rich plasma releasate inhibits inflammatory processes in osteoarthritic chondrocytes[J]. Am J Sports Med, 2011, 39(11): 2362-2370.
[6]
Sundman EA, Cole BJ, Karas V, et al. The anti-inflammatory and matrix restorative mechanisms of platelet-rich plasma in osteoarthritis[J]. Am J Sports Med, 2014, 42(1): 35-41.
[7]
Moussa M, Lajeunesse D, Hilal G, et al.Platelet rich plasma (PRP) induces chondroprotection via increasing autophagy, anti-inflammatory markers, and decreasing apoptosis in human osteoarthritic cartilage[J]. Exp Cell Res, 2017, 352(1): 146-156.
[8]
Kwon DR, Park GY, Lee SU. The effects of intra-articular platelet-rich plasma injection according to the severity of collagenase-induced knee osteoarthritis in a rabbit model[J]. Ann Rehabil Med, 2012, 36(4): 458-465.
[9]
Khatab S, van Buul GM, Kops N, et al. Intra-articular Injections of Platelet-Rich Plasma Releasate Reduce Pain and Synovial Inflammation in a Mouse Model of Osteoarthritis[J]. Am J Sports Med, 2018, 46(4): 977-986.
[10]
解光越,陈阳,张志勇,等. 富白细胞血小板血浆联合兔滑膜干细胞促进膝关节软骨损伤修复的研究[J]. 中华实验外科杂志,2017, 3(10): 1718-1720.
[11]
Yin WJ, Xu HT, Zhang CQ, et al. Advantages of Pure Platelet-Rich Plasma compared with Leukocyte- and Platelet-Rich Plasma in Treating Rabbit Knee Osteoarthritis[J]. Med Sci Monit, 2016, 22: 1280-1290.
[12]
Yin W, Xu H, Sheng J, et al. Comparative evaluation of the effects of platelet-rich plasma formulations on extracellular matrix formation and the NF-κB signaling pathway in human articular chondrocytes[J]. Mol Med Rep, 2017, 15(5): 2940-2948.
[13]
Halpern B, Chaudhury S, Rodeo SA, et al. Clinical and MRI outcomes after platelet-rich plasma treatment for knee osteoarthritis[J]. Clin J Sport Med, 2013, 23(3): 238-239.
[14]
Görmeli G, Görmeli CA, Ataoglu B, et al. Multiple PRP injections are more effective than single injections and hyaluronic acid in knees with early osteoarthritis: a randomized, double-blind, placebo-controlled trial[J]. Knee Surg Sports Traumatol Arthrosc, 2017, 25(3): 958-965.
[15]
Camurcu Y, Sofu H, Ucpunar H, et al. Single-dose intra-articular corticosteroid injection prior to platelet-rich plasma injection resulted in better clinical outcomes in patients with knee osteoarthritis: A pilot study[J]. J Back Musculoskelet Rehabil, 2018, 31(4): 603-610.
[16]
Ye Y, Zhou X, Mao S, et al. Comments on platelet-rich plasma versus hyaluronic acid in patients with hip osteoarthritis: A meta-analysis of randomized controlled trials[J]. Int J Surg, 2018, 53: 279-287.
[17]
Zhang HF, Wang CG, Li H, et al. Intra-articular platelet-rich plasma versus hyaluronic acid in the treatment of knee osteoarthritis: a meta-analysis[J]. Drug Des Devel Ther, 2018, 5(12): 445-453.
[18]
Lana JF, Weglein A, Sampson SE, et al. Randomized controlled trial comparing hyaluronic acid, platelet-rich plasma and the combination of both in the treatment of mild and moderate osteoarthritis of the knee[J]. J Stem Cells Regen Med, 2016, 12(2): 6978.
[19]
Riboh JC, Saltzman BM, Yanke AB, et al. Effect of Leukocyte Concentration on the Efficacy of Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis[J]. Am J Sports Med, 2016, 44(3): 792-800.
[20]
Burmester GR, Pope JE. Novel treatment strategies in rheumatoid arthritis[J]. Lancet, 2017, 389(10086): 2338-2348.
[21]
Tong S, Liu J, Zhang C. Platelet-rich plasma inhibits inflammatory factors and represses rheumatoid fibroblast-like synoviocytes in rheumatoid arthritis[J]. Clin Exp Med, 2017, 17(4): 441-449.
[22]
Yan S, Yang B, Shang C, et al. Platelet-rich plasma promotes the migration and invasion of synovial fibroblasts in patients with rheumatoid arthritis[J]. Mol Med Rep, 2016, 14(3): 2269-2275.
[23]
Sebastian L, Bjoern M, Holger H, et al. Intraarticular Injection of Platelet-Rich Plasma Reduces Inflammation in a Pig Model of Rheumatoid Arthritis of the Knee Joint[J]. Arthritis Rheum, 2011, 63(11): 3344-3353.
[24]
Tong S, Zhang C, Liu J, et al. Platelet-rich plasma exhibits beneficial effects for rheumatoid arthritis mice by suppressing inflammatory factors[J]. Mol Med Rep, 2017, 16(4): 4082-4088.
[25]
Avila MY. Restoration of human lacrimal function following platelet-rich plasma injection[J]. Cornea, 2014, 33(1): 18-21.
[26]
Avila MY, Igua AM, Mora AM. Randomised, prospective clinical trial of platelet-rich plasma injection in the management of severe dry eye[J]. Br J Ophthalmol, 2018.
[27]
Virzì F, Bianca P, Giammona A, et al. Combined platelet-rich plasma and lipofilling treatment provides great improvement in facial skin-induced lesion regeneration for scleroderma patients[J]. Stem Cell Research & Therapy, 2017, 8(1): 236.
[28]
Kanemaru H, Kajihara I, Yamanaka K, et al. Platelet-rich plasma therapy is eff ective for the treatment of refractory skin ulcers in patients with systemic sclerosis[J]. Mod Rheumatol, 2015, 25(4): 660-661.
[29]
Shetty S, Shenoi SD. Autologous platelet-rich fibrin in treatment of scleroderma ulcer[J]. Int Wound J, 2016, 13(5): 1065-1066.
[30]
Rallis E, Falidas E, Villias C. Amyopathic dermatomyositis-associated bilateral elbow ulcers successfully treated with autologous platelet-rich plasma[J]. Int J Dermatol, 2014, 53(1): 150-152.
[31]
Sriram S, Sankaralingam R, Mani M, et al. Autologous platelet rich plasma in the management of non-healing vasculitic ulcers[J]. Int J Rheum Dis, 2016, 19(12): 1331-1336.
[32]
艾智华,万勇,刘君静,等. 自体富血小板凝胶治疗痛风石合并慢性溃疡的疗效观察[J]. 四川大学学报(医学版), 2015, 46(5): 770-772.
[1] 马晓菊, 梁潇, 段云友, 袁丽君, 赵萍. NBAV脂质纳泡对ApoE -/-小鼠动脉粥样硬化病变的评估和干预[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 608-616.
[2] 程燕妮, 樊菁, 肖瑶, 舒瑞, 明昊, 党晓智, 宋宏萍. 乳腺组织定位标记夹的应用与进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 361-365.
[3] 周荷妹, 金杰, 叶建东, 夏之一, 王进进, 丁宁. 罕见成人肋骨郎格汉斯细胞组织细胞增生症被误诊为乳腺癌术后骨转移一例[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 380-383.
[4] 王振宇, 张洪美, 荆琳, 何名江, 闫奇. 膝骨关节炎相关炎症因子与血浆代谢物间的因果关系及中介效应[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 467-473.
[5] 徐志刚, 曹涛, 何亭, 李博奥, 魏婧韬, 张栋梁, 官浩, 杨薛康. 采用抗生素骨水泥治疗糖尿病患者心脏术后胸骨骨髓炎的临床效果观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 498-502.
[6] 林同辉, 杨卫玺. 股前外侧穿支皮瓣在电烧伤治疗中应用的研究进展[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 526-530.
[7] 李亚龙, 王星童, 申传安. 异体富血小板血浆在创面修复中的临床应用进展[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 541-545.
[8] 唐丹萍, 王萍, 江孟蝶, 杨晓蓉. 自体脂肪移植在乳腺癌术后乳房重建的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 582-585.
[9] 王苏睿, 胡根, 邵国益. A 型肉毒杆菌毒素在腹腔开放后腹壁缺损修复中的应用[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 649-653.
[10] 袁园园, 岳乐淇, 张华兴, 武艳, 李全海. 间充质干细胞在呼吸系统疾病模型中肺组织分布及治疗机制的研究进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 374-381.
[11] 严虹霞, 王晓娟, 张毅勋. 2 型糖尿病对结直肠癌患者肿瘤标记物、临床病理及预后的影响[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 483-487.
[12] 陈倩倩, 袁晨, 刘基, 尹婷婷. 多层螺旋CT 参数、癌胚抗原、错配修复基因及病理指标对结直肠癌预后的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 507-511.
[13] 谭瑞义. 小细胞骨肉瘤诊断及治疗研究现状与进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 781-784.
[14] 王曦娅, 尹弘青, 丁伟, 徐滨, 于海源, 马东升, 邵军. 桥本背景下甲状腺乳头状癌多参数分析预测大容量淋巴结转移[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 548-554.
[15] 耿晓坤. 缺血性卒中后无效再灌注的时间窗、组织窗与神经保护[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(06): 636-636.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?